OSE Immunotherapeutics SA ORPOF
$4.43
Last Updated: Jun 02, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
ORPOF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, OSE Immunotherapeutics SA is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
OSE Immunotherapeutics SA. Stock Analysis ORPOF
United States Health Care Micro Cap OSE Immunotherapeutics SA s is a biotechnology company, which engages in the research and development of pharmaceutical products. The company develops immunotherapies, directly or through partnerships, for the activation and regulation of the immune system in immuno-oncology and in autoimmune diseases. The firm's research and development in immunology is based on 3 platforms, such as T cell-based vaccines, Immuno-Oncology (myeloid targets) and Auto-Immunity & Inflammation. The company provides technological and scientific platforms: neoepitopes, agonist or antagonist monoclonal antibodies, ideally positioned to fight cancer and autoimmune diseases.
OSE Immunotherapeutics SA (ORPOF) Chart
Financial Metrics & Statements of OSE Immunotherapeutics SA (ORPOF)
FAQ's for OSE Immunotherapeutics SA (ORPOF)
- As of August 2026, OSE Immunotherapeutics SA ORPOF is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes OSE Immunotherapeutics SA using these criteria to determine its compliance status.
- Muslim investors may consider investing in OSE Immunotherapeutics SA if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of OSE Immunotherapeutics SA by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of OSE Immunotherapeutics SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of OSE Immunotherapeutics SA on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for OSE Immunotherapeutics SA (ORPOF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
